The effect of topical bevacizumab as an adjunctive therapy for corneal neovascularization

Acta Ophthalmol. 2013 May;91(3):e246-8. doi: 10.1111/j.1755-3768.2012.02540.x. Epub 2012 Sep 23.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Topical
  • Adolescent
  • Adult
  • Aged
  • Angiogenesis Inhibitors / administration & dosage*
  • Antibodies, Monoclonal, Humanized / administration & dosage*
  • Bevacizumab
  • Corneal Neovascularization / drug therapy*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Treatment Outcome
  • Vascular Endothelial Growth Factor A / antagonists & inhibitors
  • Visual Acuity / physiology
  • Young Adult

Substances

  • Angiogenesis Inhibitors
  • Antibodies, Monoclonal, Humanized
  • VEGFA protein, human
  • Vascular Endothelial Growth Factor A
  • Bevacizumab